METHERINE FORTE

This brand name is authorized in Nigeria.

Active ingredients

The drug METHERINE FORTE contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII C7D6T3H22J - ARTEMETHER
 

Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas.
 
Read more about Artemether
2
UNII F38R0JR742 - LUMEFANTRINE
 
Read more about Lumefantrine

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-4737 Tablet METHERINE FORTE TABLET TAB 80 mg; 480 mg 1X6 METHERINE FORTE TABLET ARTEMETHER & LUMEFANTRINE ARTEMETHER 80mg & LUMEFANTRINE 480mg Maize Starch--41.40mg Microcrystalline Cellulose-18mg Crospovidone--8mg PVP K-30--10mg Sodium Benzoate-0.6 Isopropyl -Alcohol--qs Purified Talc-10mg Crospovidone--10mg Colloidal Anhydrous Silica --17mg(Aerosil)-- Magnesium Stearate--25mg Spray tab Yellow--5mg Methylene dichloride--qs Isopropyl -Alcohol--qs A4-4737 Drugs Imported Products 1X6 Prescription Only Medicine (POM) 14/11/2022 APHANTEE PHARM NIGERIA LTD, SUITE FF 11, PACIFIC COMPLEX AWKA ROAD ONITSHA ANAMBRA 8077261675 aphanteepharm@yahoo.com MAXHEAL LABORATORIES PVT. LTD., 2-7/80-85, SURSEZ SACHIN, GUJARAT-394230 INDIA, India 26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
P01BF01 Artemether and lumefantrine P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BF Artemisinin and derivatives, combinations
Discover more medicines within P01BF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-4737

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈